Hydrocortisone Butyrate
10 NDCs across 4 manufacturers|10 Generic,0 Brand
Hydrocortisone Butyrate is used to treat congenital adrenal hyperplasia, adrenal insufficiency, ulcerative colitis, contact dermatitis, facial dermatoses and foot dermatoses, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 31, 1982, and the first generic was approved Jan 14, 2004. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $6 million on Hydrocortisone Butyrate across 16,000 claims for 6,438 beneficiaries.
Hydrocortisone Butyrate is available as 10 NDCs from 4 manufacturers (10 generic, 0 brand), with NADAC prices from $1.77 to $2.51 per GM — a 42% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
10G / 0B
Manufacturers
4
competing in market
Price Spread
$1.77 – $2.51
per GM, 6 of 10 NDCs
7d Activity
avg +1.5% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
4 manufacturers producing HYDROCORTISONE BUTYRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
HYDROCORTISONE BUTYR 0.1% OINT | $2.5088 per GM | — |
HYDROCORTISONE BUTY 0.1% CREAM | $2.3899 per GM | +0.24% |
HYDROCORTISONE BUTY 0.1% CREAM | $2.3281 per GM | +2.81% |
HYDROCORTISONE BUTYR 0.1% SOLN | $2.1764 per ML | — |
HYDROCORTISONE BUTYR 0.1% OINT | $2.0418 per GM | — |
HYDROCORTISONE BUTYR 0.1% OINT | $1.8725 per GM | — |
HYDROCORTISONE BUTYR 0.1% SOLN | $1.8575 per ML | — |
HYDROCORTISONE BUTYR 0.1% OINT | $1.7675 per GM | — |
HYDROCORTISONE BUTYR 0.1% LOTN | $0.6999 per ML | — |
HYDROCORTISONE BUTYR 0.1% LOTN | $0.6999 per ML | — |
Frequently Asked Questions
What is Hydrocortisone Butyrate used to treat?
Hydrocortisone Butyrate is used to treat congenital adrenal hyperplasia, adrenal insufficiency, ulcerative colitis, contact dermatitis, facial dermatoses and foot dermatoses, per the National Library of Medicine's MED-RT classification.
When did Hydrocortisone Butyrate become available as a generic?
FDA approved the first generic Hydrocortisone Butyrate (ANDA) on Jan 14, 2004. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Hydrocortisone Butyrate?
In 2024, Medicare Part D spent $6 million on Hydrocortisone Butyrate across 16,000 claims for 6,438 beneficiaries.
How many Hydrocortisone Butyrate products are on the market?
The Hydrocortisone Butyrate drug market contains 10 NDCs from 4 manufacturers — 10 generic and 0 brand products.
What is the price range for Hydrocortisone Butyrate?
NADAC reference prices for Hydrocortisone Butyrate range from $1.7675 to $2.5088 per GM — a 42% difference between cheapest and most expensive. 4 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Hydrocortisone Butyrate?
4 manufacturers list Hydrocortisone Butyrate in NADAC. Ranked by number of NDCs, the largest are Taro Pharmaceuticals U.S.A. Inc. (6), Oceanside Pharmaceuticals (2), The J. Molner Company LLC (1), Lupin Pharmaceuticals Inc. (1).
How has the price of Hydrocortisone Butyrate changed recently?
Over the past 7 days, 2 Hydrocortisone Butyrate NDCs rose and 0 fell, with a market-wide average change of +1.5%.